Donate
News + Publications
Careers
Make a Gift
Contact
Back
Who
We Are
Board of Directors + Governance
Our Leadership
Our Team
Our Partners
Our Benefactors
Our History
Our Financials
Health Impact Reports
Our
Programs
All Programs
Accelerating Medicines Partnership® (AMP®)
Biomarkers Consortium
GeneConvene Global Collaborative
RECOVER – Treating Long COVID
Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV)
Azithromycin Prevention in Labor Use Study (A-PLUS)
Master Protocol for Treatment of Non-Small Cell Lung Cancer (Lung-MAP)
Partnership For Accelerating Cancer Therapies (PACT)
Edmond J. Safra Family Lodge
Education & Training Programs
Fighting
Diseases
All Disease
Cancer
Cardiovascular
Infectious Diseases
Inflammation + Immunity
Metabolic Disorders
Neuroscience
Rare Diseases
Powering
Science
FNIH Awards Ceremony
Trailblazer Prize for Physician-Scientists
Charles A. Sanders, MD Partnership Award
The Kovler Prize for Trust in Life Science Journalism
The Deeda Blair Research Initiative for Disorders of the Brain
Research Support
Fellowships & Training
Lectures
Team Science Day 2024
Patient
Voices
Patient and Family Resources
Donate
Partner With Us
Measurable Residual Mutated NPM1 before Allogeneic Transplant for Acute Myeloid Leukemia
